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Leptin is known to inhibit appetite and promote energy metabolism in vertebrates. Leptin
resistance (LR) commonly occurs in diet-induced obesity (DIO) in mammals. However,
the roles of leptin in the energy homeostasis in DIO animals with LR remain unclear. Here
we first verified the high expression of leptin in subcutaneous adipose tissue (SCAT) as
in liver in Nile tilapia. Furthermore, we produced two types of DIO Nile tilapia by using
a high-carbohydrate diet (HCD) or a high-fat diet (HFD), and confirmed the existence
of LR in both models. Notably, we found that HCD-DIO fish retained leptin action in the
activation of lipid metabolism and showed LR in glucosemetabolism regulation, while this
selective leptin action between lipid and glucose metabolism was reversed in HFD-DIO
fish. Fasting the fish for 1 week completely recovered leptin actions in the regulation
of lipid and glucose metabolism. Therefore, leptin may retain more of its activities in
animals with LR than previously believed. Evolutionally, this selective regulation of leptin
in nutrients metabolism could be an adaptive mechanism in animals to store surplus
calories when different types of food are abundant.
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INTRODUCTION
The cytokine leptin was first identified in mouse adipose tissue by positional cloning in 1994
(1). Mammalian leptin is an adipostatic hormone which plays a key role in feeding control and
energy homeostasis (2). In most cases of obesity, the hyperleptinemia neither reduces appetite nor
reverses weight gain. Under such condition, the administration of exogenous leptin has no effect.
This condition has been termed as “leptin resistance” (LR) (3). Although several mechanisms of
LR have been proposed (4), recent data obtained using a leptin receptor antagonist demonstrated
that hyperleptinemic diet-induced obesity (DIO) mice retained leptin action (5). Consequently,
the term “leptin resistance” with more than 4,000 citations has recently been redefined (6, 7).
However, the role of leptin in DIO is still unclear. Most studies on LR have focused on exploring
the mechanisms to reducing obesity using leptin, but ignored leptin original function from the
perspective of adaptive evolution (8). Given that teleosts are the first true vertebrates on earth,
the physiological roles of teleostean leptin should be original and best represented (9). Therefore,
understanding the role of teleostean leptin in metabolic regulation could help to reveal the
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evolution of energy homeostasis in vertebrates (10). Moreover, a
fish model could help to explore the original features of LR.
However, little is known about LR in teleosts at present. Owing
to the poor conservation of the leptin amino acid sequences
between mammals and teleosts, the first teleostean leptin was
cloned more than a decade after it was first cloned in mammals
(11). Nonetheless, strong conservation of the tertiary structure
throughout the vertebrates and the same anorexigenic effect
upon leptin administration suggested the conservation of leptin
action (12). Unlike in mammals, in which adipose tissue is the
primary site for leptin synthesis, in fish leptin was reported to
be mainly expressed in the liver (8). Furthermore, owing to the
less pronounced lipolytic action of teleostean leptin coupled with
its clearer glycometabolic action, some researchers demonstrated
that teleostean leptin may play a greater role as a glucoregulatory
hormone than an adipostatic factor (10, 13). However, the roles of
leptin in fish which under over-nutrition statuses are still unclear.
In this study, we fedNile tilapia (Oreochromis niloticus), which
is an ideal fish model for nutritional and metabolic studies (14),
a high-carbohydrate diet (HCD) or a high-fat diet (HFD) and
subjected it to Nile tilapia recombinant leptin A (NtrelepA)
treatment. The aims were (i) to determine the function of leptin
in Nile tilapia, (ii) to verify the existence of LR in Nile tilapia,
and (iii) to assess the action of leptin in DIO Nile tilapia. For
the first time, our study confirms the existence of LR in DIO
Nile tilapia and demonstrates a selective leptin action in nutrients
metabolism in HCD-DIO Nile tilapia and HFD-DIO Nile tilapia
which could be an adaptive strategy for surplus calorie storage.
MATERIALS AND METHODS
Experimental Animals
All-male Nile tilapia were purchased from Bairong Fish Farm in
Qingyuan (Guangdong, China) and were maintained at 28± 1◦C
in the circulating water system with a 12D:12L photoperiod. The
fish were acclimated for 1 week before the study. All experiments
were conducted under the Guidance of the Care and Use of
Laboratory Animals in China. This research was approved by the
Committee on the Ethics of Animal Experiments of East China
Normal University.
Preparation of NtrelepA
Nile tilapia has two isoforms of leptins namely; leptin A and
leptin B. Leptin A (LepA), which is the dominant leptin ortholog
(15) was used in this study. NtrelepA was expressed in the
TransB (DE3) chemically competent cell (TransGen, China).
A pair of primers (Table S1) was used to obtain the fragment
encoding the mature protein of Nile tilapia Leptin A (LepA)
(Ala21-Cys161) with 6 tandem histidine at the N-terminal.
The fragment was digested by using NdeI and XhoI (TaKaRa,
Japan) before it was cloned into the same restriction-enzyme
sites in pET-32a (+) (Novagen, Germany). Heat shock method
was used to transform the recombinant plasmid into TransB
(DE3) chemically competent cell for protein expression. The
Ni-NTA column (Yelibio, China) was used to purify the fusion
protein and the purified buffer was replaced with saline buffer
by dialysis membranes (Yuanyebio, China). The purified protein
was detected by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and was identified by
matrix-assisted laser desorption/ionization-time of flight
mass spectrometry (MALDI-TOF-MS) (Figures S1A,B). The
concentration of NtrelepA was determined by the bicinchoninic
acid (BCA) kit (KWBIO, China). The activity of NtrelepA was
determined by intraperitoneal injection (i.p.) of NtrelepA in
Nile tilapia. The blood glucose level increased gradually with
an increase of NtrelepA concentration, suggesting the normal
activity of NtrelepA (Figure S1C).
Fish Feeding and Intraperitoneal (i.p.)
Injections
The fish used for LepA expression profile and NtrelepA i.p.
injection were fed twice daily to visual satiation by using a
commercial diet (Tongwei, China) for 4 weeks (final weight 13
± 2 g). After fasting the fish for overnight, foregut, spleen, heart,
kidney, visceral adipose tissue (VAT), red muscle, white muscle,
brain, gill, skin and liver were collected for LepA expression
profile. To assess the in vivo regulation of NtrelepA in appetite
and metabolism, Nile tilapia were divided into two groups and
each group received a single i.p. injection of NtrelepA (400 ng/g
BW) or saline (30 fish each group). The fish were given enough
feeds and allowed to consume the feeds for 15min at 1, 2, 4,
7, 11 h after administration. During this period, the amount of
food intake at each time point was recorded and the cumulative
food intake during the 11 h in both groups were calculated and
compared. Two hours after administration of NtrelepA or saline,
six unfed fish in each group were removed to collect blood, liver,
hypothalamus and muscle for biochemical or molecular assays.
In another experiment, some Nile tilapia were used to
establish DIO models. Fish were fed a normal diet (ND; 4%
fat and 32.9% corn starch), a high-carbohydrate diet (HCD; 4%
fat and 44.9% corn starch), or a high-fat diet (HFD; 16% fat
and 32.9% corn starch) (Table S2). Body weights of the fish in
each treatment were measured weekly. The fish were fed on the
respective diets daily at a feeding rate of 5% body weight for
8 weeks. To investigate the physiological changes of the DIO
models, six fish from each diet were fasted for overnight and
sacrificed by anesthetizing them with MS-222 (0.1 g/L). The
liver and VAT were collected and weighed, and the muscle,
hypothalamus, subcutaneous adipose tissue (SCAT) and plasma
were collected from each sacrificed fish. To determine the actions
of leptin in food intake regulation under DIO states, 12 fish
were sampled from each dietary treatment and divided into two
groups. One group received an i.p. injection of NtrelepA (400
ng/g BW) while the other group was i.p. injected with saline. Two
hours after injection, the fish were fed a single meal with enough
feeds and the food intake was counted after 15min.
To monitor the weight of nine fish from each dietary
treatment received an i.p. administration of NtrelepA (400 ng/g
BW) or saline. Two hours after injection, fish were given a single
meal with enough feed and the weight gain was calculated after
24 h of injection. For metabolic assays, 12 fish from each dietary
treatment were divided into two groups. Each group received an
i.p. injection of NtrelepA (400 ng/g BW) or saline. Two hours
after treatment, plasma, liver, hypothalamus and muscles were
collected. To study the action of leptin restoration, 12 fish from
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each dietary group were deprived of feeds for 1 week followed
by feeding for 8 weeks. The fish were then divided into two
groups and were i.p. injected with NtrelepA (400 ng/g BW) or
saline. Two hours after treatment, plasma, liver and muscles were
collected. All fish were anesthetized with MS-222 (0.1 g/L) before
sampling and the samples were immediately frozen in liquid
nitrogen, followed by storage at-80◦C until used.
Quantitative Real-Time PCR
Total RNA was isolated using TransZolTM (TransGen, China)
and reverse-transcribed using the PrimeScriptTM RTMaster Mix
Kit (Takara, Japan). qPCR was performed in a CFX96 real-time
PCR system (Bio-Rad, USA) using SYBR Mix (KWBIO, China).
Pre-validated primers spanning exon-exon boundaries were used
for amplifications and each PCR run was performed in duplicate.
Elongation factor 1 alpha (EF1a) was used as reference gene. All
primer sequences are listed in Table S1.
Fatty Acid β-Oxidation
The fatty acid (FA) β-oxidation assay was performed as
previously reported in our previous study (16). The Nile tilapia
liver tissues treated with NtrelepA or saline were weighed
and homogenized (1:40, w/v) in ice-cold 0.25 M-sucrose
medium containing 2 mM-EGTA and 10 mM-Tris-HCl, pH
7.4. The homogenates were used for immediate measurements
of [1-14C] palmitic acid (PerkinElmer) β-oxidation. Tri-Carb
4910TR Liquid Scintillation Analyzer (PerkinElmer) was used for
radioactivity measurements.
[1-14C] D-Glucose Tracer Assay
A sample of six fish (about 13 ± 2 g) from each treatment group
were starved for overnight and first received i.p. injection of
NtrelepA or saline, followed by i.p. injection of [1-14C] D-glucose
(50µCi/kg BW, PerkinElmer) 1 hour after the first injection. One
hour after the second injection, the whole fish was digested by
using a digestion solvent (70% HClO4/30% H2O2, v/v) (1:5, w/v)
at 6◦C in a water bath for 12 h. The radioactivity of whole fish
was measured in Tri-Carb 4910TR Liquid Scintillation Analyzer
(PerkinElmer).
Glucose/Insulin Tolerance Tests
For intraperitoneal glucose tolerance test (GTT), fish were fasted
for overnight, followed by an i.p. injection of D-glucose (500
mg/kg BW, 20% in 0.85% NaCl) (Sigma, Germany). Plasma
glucose levels weremeasured using a glucose assay kit (Jiancheng,
China) at 0, 30, 90, and 180min after injection. For one time
point GTT with NtrelepA administration, fish received NtrelepA
administration first, then i.p. injection of D-glucose 1 h after
NtrelepA injection. Plasma glucose levels were determined 1 h
after D-glucose injection. For intraperitoneal insulin tolerance
test (ITT), fish were fasted for 4 h and were i.p. injected with
bovine insulin (0.75 U/kg BW) (Sigma, Germany). Glucose levels
were determined 90min after injection as described above.
Histological and Cytological Analyses
Liver, SCAT (including muscle and skin), and VAT (at least
four fish from each group) were fixed in 4% paraformaldehyde
(Servicebio, China) and embedded in paraffin as described
previously (17). Paraffin blocks were sectioned at 6µm thickness
using a microtome, followed by hematoxylin and eosin (H &
E) (Sigma). The H & E staining was carried out following
a standard procedure Reference(s). For immunohistochemistry
(IHC) staining of liver and SCAT, paraffin-sectioned samples
were pretreated in citrate buffer and digested by using microwave
oven for antigen repair in 3% H2O2 for 25min and blocked
in 3% BSA for 30min. LepA-specific rabbit polyclonal antibody
(HuaAn, China) was added in the blocking solution (1:200)
and incubated at 4◦C for overnight. Sections were washed
with phosphate buffered saline (PBS) and incubated with goat
anti-rabbit IgG-HRP (HuaAn, China) secondary antibody for
1 h at room temperature. The signal was detected by 3,3′-
diaminobenzidine (DAB) kit (Servicebio, China).
Measurements of Hormones and
Metabolites
Enzyme-linked immunosorbent assay (ELISA) kits were used
to measure plasma insulin, glucagon and leptin levels (mlbio,
China). The plasma glucose, triglyceride (TG), non-esterified
fatty acid (NEFA), hepatic TG and glycogen and muscle glycogen
were determined by colorimetric enzymatic assays (Jiancheng,
China), according to the manufacturer’s protocols. Total lipid
contents (percent dry weight) in whole Nile tilapia were
measured using the Folch procedure as previously described (18).
Western Blot Analysis and Antibodies
Protein extraction and SDS-PAGE were performed as described
previously (14). Rabbit polyclonal antibody, β-actin and GAPDH
were purchased from SunGene Biotech (SunGene, China). LepA-
specific rabbit polyclonal antibody was obtained from HuaAn
Biotech (HuaAn, China). Signal transducers and activators
of transcription 3 (STAT3) and phosphorylation of STAT3
(p-STAT3) rabbit polyclonal antibodies were purchased from
Elabscience Biotech (Elabscience, China).
Transcriptomic Assay
Nine hepatic RNA samples (three from each dietary treatment
group) were prepared after feeding trial. The libraries were deep
sequenced with the Illumina Hiseq 2500 platform. The raw reads
were filtered for quality control as described previously (19). The
whole set of original sequences are available in the NCBI Short
Read Archive under accession number SRP120142.
Differentially Expressed Genes (DEGs) and
Function Enrichment Analyses
Clean RNA-seq reads were mapped to the Nile tilapia reference
genome. The expression level of transcripts was normalized using
fragments per kilobase of transcript per million mapped (FPKM)
reads method. DEGs analysis across groups was determined
using edgeR package (http://www.rproject.org/). In the present
study, the genes with fold change ≥2 and FDR ≤0.05 were
deemed to be the significant DEGs. Gene Ontology (GO) and
Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment
analysis were conducted basing on the DEGs.
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Statistical Analysis
Results are presented as mean ± SEM. Data were tested
for normality using Shapiro–Wilk test and homogeneity of
variance using Levene’s test. Comparisons between two groups
were performed by using two-tailed independent t–test. Results
with P < 0.05 were considered to be significant. Analyses
were performed using GraphPad Prism (GraphPad, San Diego,
California, USA).
RESULTS
LepA Expression Profile in Nile Tilapia
To determine the tissue distribution of LepA in Nile tilapia, a
total of 11 tissues were sampled for qPCR analysis. Consistent
with the findings of many studies in fish, the highest LepA
mRNA expression levels were obtained in the liver (Figure 1A).
Surprisingly, the organ with the second highest expression was
the skin. Further analysis by using IHC with a LepA-specific
antibody indicated that LepA is expressed in liver and SCAT
(Figures 1B,C). These results confirm that SCAT is another site
which has high expression of LepA.
LepA Regulates Food Intake and Activates
Catabolism in Nile Tilapia
To investigate whether LepA has an anorexic effect and
activates catabolism, we examined the physiological responses
to acute leptin treatment. NtrelepA was obtained by an
E. coli-derived method. We conducted intraperitoneal (i.p.)
injection of NtrelepA (400 ng/g BW) (20) and the food
intake at 1, 2, 4, 6, 7, 11 h after NtrelepA treatment were
measured. The final cumulative food intake was reduced
significantly after 1–7 h after NtrelepA treatment (Figure 2A).
This confirms that LepA has an acute anorexic effect in Nile
tilapia.
Furthermore, 2 h after NtrelepA treatment, the plasma
TG levels decreased, and the NEFA, glucose, and glucagon
levels increased, while there was no change in insulin levels
(Figure 2B). As a response to these changes, liver TG content
was decreased and FA β-oxidation in liver was enhanced
(Figures 2C,D). In addition, liver glycogen content decreased
and the reservation of injected [14C] glucose in the body also
decreased (Figures 2E,F).
To better understand the molecular basis of these effects,
we analyzed the expression of genes involved in appetite and
metabolism under NtrelepA treatment. Consistent with
previous report (21), the hypothalamic leptin signaling
pathway was activated by inducing leptin receptor (LepR)
mRNA expression, decreasing NPY mRNA expression, and
also promoting mRNA expression of the negative feedback
regulator, SOCS3 (Figure 2G). The mRNA levels of genes
involved in lipolysis (ATGL) and lipid transport (apoE), were
significantly increased in the liver after NtrelepA treatment
(Figure 2H). NtrelepA also increased the hepatic expression
of Glut2, the key glucose transporters (Gluts) in whole-
body glucose utilization (22) (Figure 2I). These findings
suggest that LepA activates the catabolism of lipid and
glucose.
Production of DIO Nile Tilapia Model
In mammals, LR is tightly correlated with obesity. To produce
the DIO Nile tilapia model and also evaluate the roles of
hyperleptinemia in different nutritional statuses, we fed the
fish a diet containing either 44.9% corn starch (HCD) or
16% fat (HFD), and 4% fat with 32.9% corn starch as a
normal diet (ND). After 8 weeks of feeding, the mean body
weights of the fish in the HCD and HFD groups were 9
and 13% higher than that of the ND-fed fish, respectively
(Figure 3A). Correspondingly, significantly higher fat deposition
in whole body, liver, VAT, and SCAT was obtained in
the HCD- and HFD-fed fish than those in the control
(Figures 3B,C,J–L). Compared to HCD, HFD-fed fish had higher
fat deposition (Figures 3B,C). Notably, HCD induced a larger
mass of SCAT than HFD (Figure 3L). Both HCD and HFD
increased significantly hepatic TG content and plasma TG levels
(Figures 3D,G). More muscle glycogen was accumulated in
HCD-fed fish, however no significant differences were observed
among three groups in plasma glucose, insulin and hepatic
glycogen (Figures 3E,F,H,I). Moreover, HCD decreased PPARα
mRNA levels and increased expression of periostin, while HFD
increased PPARγ and RBP4 mRNA levels in liver (Figure 3M).
Additionally, GTT and ITT showed that HFD induced insulin
resistance while HCD-fed fish had normal insulin sensitivity
(Figures 3N,O).
To systemically elucidate the metabolic characteristics of
DIO fish, we carried out global transcriptome analysis. The
well-matched RNA-Seq and qPCR analyses of the expression
of 24 genes indicated the reliability of the RNA-Seq data
(Figure 4A). There were 1,578 different expression genes (DEGs)
in HFD, but only 388 DEGs in HCD, when compared to
ND. Moreover, there were only nine common DEGs in
the three pairwise groups (Figure 4B). Classification analysis
showed that the pathway that was predominantly affected
by the HCD was “metabolism” while that by the HFD
was “organismal systems” (Figure 4C). We also created a
schematic illustration of the DEGs involved in the major
metabolic pathways. Interestingly, HCD-fed fish showed more
activity in lipid catabolism, while HFD-fed fish were more
active in glucose catabolism (Figure 4D). Taken together, these
findings indicate that both HCD and HFD induced DIO Nile
tilapia, however, the two DIO models had distinct metabolic
characteristics.
Leptin Resistance Occurred in DIO Nile
Tilapia
Hyperleptinemia is an important characteristic of DIOmice (23).
However, little is known about the expression of leptin in DIO
teleosts. Consistent with the findings in DIO mice, Nile tilapia
fed HCD or HFD showed elevated plasma leptin (Figure 5A).
To find out the source of the plasma leptin, we determined
the mRNA expression of LepA in liver and SCAT, and found
that higher LepA mRNA expression in HFD- and HCD-fed fish
occurred in liver and SCAT, respectively (Figures 5B,C). This
was confirmed by western blotting and IHC (Figures 5E–H).
Thus, DIO Nile tilapia showed hyperleptinemia, but the main
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FIGURE 1 | Expression profile of LepA in Nile tilapia. (A) LepA mRNA levels in 11 tissues. White M (white muscle), Red M (red muscle), VAT (visceral adipose tissue),
Skin+ (skin and subcutaneous adipose tissue), (n = 3). (B) IHC for LepA (brown, indicated by red arrows) in liver. Scale bars, 50µm. (C) IHC for LepA (brown,
indicated by red arrows) in SCAT. Scale bars, 50µm.
FIGURE 2 | Physiological functions of LepA in Nile tilapia. (A) Accumulated food intake rate, (n = 3, 5 fish each parallel). (B) Plasma TG (n = 6), NEFA (n = 6), glucose
(n = 7), glucagon and insulin (INS) levels (n = 5). (C) Liver TG content (n = 6). (D) Total β-oxidation of [1-14C] palmitate in the liver homogenates (n = 6). (E) Liver
glycogen content (n = 6). (F) Reservation of [1-14C] D-glucose in body (n = 6). (G) LepR, SOCS3 and NPY mRNA in hypothalamus (n = 6). (H) ATGL and apoE
mRNA in liver (n = 6). (I) Glut2 mRNA in liver (n = 6). *p < 0.05 and **p < 0.01. Data shown as means ± SEM.
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FIGURE 3 | Body composition and metabolic characteristics of DIO Nile tilapia induced by HCD or HFD feeding. (A) Body weight changes. #HFD vs. HCD, &HCD
vs. ND, #P < 0.05, &P < 0.05, ##P < 0.01 and &&P < 0.01 (n = 3, 120 fish per group). (B) Whole fish fat content (100% × fat weight/body weight, dry weight
ratio) (n = 6). (C) Visceral adipose tissue-somatic index (VSI) (100 × visceral adipose tissue weight / body weight, wet weight ratio) (n = 6). (D) Liver TG content
(n = 6). (E) Muscle glycogen content (n = 6). (F) Liver glycogen content (n = 6). (G–I) Plasma TG, glucose and insulin levels (n = 6). (J–L) H&E staining of liver, VAT
and SCAT. Three column graphs in the right of pictures from top to bottom represent hepatocyte size, adipocyte size and thickness of SCAT, respectively. Scale bars,
100µm. (M) PPARα and PPARγ mRNA levels in liver (n = 6). (N,O) GTT (n = 5) and ITT (n = 6). *p < 0.05 and **p < 0.01. Data shown as means ± SEM.
sites of LepA synthesis differed between HCD- and HFD-DIO
fish.
In mammals, hyperleptinemia involves enhancement of the
leptin signaling pathway, but this is weakened in DIO mice (24).
Accordingly, we examined the genes at downstream of leptin
signal transduction and p-STAT3 in the hypothalamus. Feeding
fish with HCD or HFD, and especially the former, induced
both SOCS3 and PTP1B mRNA expression in the hypothalamus
(Figure 5D). Accordingly, the expression of NPY mRNA was
increased in HCD- and HFD-fed fish (Figure 5D). Similarly,
levels of p-STAT3 decreased significantly in HCD- and HFD-fed
fish, but this was more pronounced in HCD-fed fish (Figure 5I).
Moreover, NtrelepA administration increased p-STAT3 in ND-
fed fish, but this effect was attenuated in HCD- and HFD-fed
fish (Figure 5J). Thus, DIONile tilapia showed a hyperleptinemic
state with impaired leptin signaling.
Based on this, we examined the in vivo effects of peripheral
leptin on food intake and 24 h-weight gain after NtrelepA
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FIGURE 4 | Comparative transcriptomic analysis of HCD or HFD-induced obese Nile tilapia. (A) Validation of RNA-Seq data by qRT-PCR. The left profile shows
mRNA expression patterns of 24 representative genes detected by RNA-Seq, and the right one is the corresponding verification results by qRT-PCR. EF1α was used
as an internal control. (B) The number of DEGs among all samples. (C) Distribution by categories of DEGs when compared HCD and HFD treatment to control. FDR
≤ 0.05 and |log2 (fold change)| ≥1 were set as the thresholds to identify DEGs. (D) DEGs involved in metabolic pathways of DIO Nile tilapia. Relative expression levels
were normalized based on the Z-score and are shown on a color gradient from low (green) to high (red). GCK, glucokinase; PK, pyruvate kinase; LDH, lactate
dehydrogenase; G6Pase, glucose 6-phosphatase; F1,6BPase, fructose 1,6-bisphosphatase; PEPCKc, phosphoenolpyruvate carboxykinase cytosol isozyme; GK,
glycerol kinase; ALDH9A1, aldehyde dehydrogenase 9 family, member A1; BCAT2, branched-chain-amino-acid aminotransferase; SHMT, serine
hydroxymethyltransferase; EAAT1, excitatory amino acid transporter 1; SLC7A11, solute carrier family 7 member 11; SLC6A4, solute carrier family 6 member 4;
SNAT2, sodium-coupled neutral amino acid transporter 2; SNAT3, sodium-coupled neutral amino acid transporter 3; SLC43A1, solute carrier family 43 member 1;
ACOX3, acyl-coenzyme A oxidase 3; CACT, carnitine-acylcarnitine translocase; FABP1, fatty acid-binding protein 1; ACSBG, acyl-CoA synthetase, bubblegum
Family; ACSL, long chain fatty acid-CoA ligase; ApoE, apolipoprotein E; DGAT, diglyceride acyltransferase; HSL, hormone-sensitive lipase; ATGL, adipose triglyceride
lipase; MPC1, mitochondrial pyruvate carrier 1; SLC25A11, solute carrier family 25 member 11; PDHc, pyruvate dehydrogenase complex; PEPCKm,
phosphoenolpyruvate carboxykinase mitochondrial isozyme; CPT1, carnitine palmitoyl transterase 1; ACADL, acyl-CoA dehydrogenase long chain; HADHA,
hydroxyacyl-Coenzyme A dehydrogenase; ACAT1, acetyl-CoA acetyltransferase 1; HMGCL, hydroxymethylglutaryl-CoA lyase; CS, citrate synthase; IDH, isocitrate
dehydrogenase; OGDH, ketoglutarate dehydrogenase.
injection. NtrelepA treatment clearly decreased food intake and
weight gain in ND fish, but these effects were eliminated in
both HCD and HFD groups (Figures 5K,L). Hyperleptinemic
DIO mice with blunted anorectic responsiveness to exogenous
leptin administration are commonly referred to as exhibiting
LR (3). Our results indicate for the first time that LR occurs
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FIGURE 5 | DIO Nile tilapia presented hyperleptinemia and LR. (A) Plasma Leptin levels (n = 5). (B,C) LepA mRNA levels in liver and SCAT (n = 6). (D) SOCS3,
PTP1B and NPY mRNA levels in hypothalamus (n = 6). (E,F) Western blot analysis of LepA in liver and SCAT, and column diagram shows as LepA relative to GAPDH
(n = 4). (G,H) IHC for LepA (brown, indicated by red arrows) in liver and SCAT. Scale bars, 50µm. (I) Western blot analysis of p-STAT3 in hypothalamus, and column
diagram is shown as p-STAT3 relative to STAT3 (n = 4). (J) Hypothalamic p-STAT3 with NtrelepA administration. (K) Food intake rate at 2 h after NtrelepA or saline
treatment (n = 6). (L) 24-h weight gain after NtrelepA or saline treatment. NtrelepA group (9 ND fish, 8 HCD fish, and 9 HFD fish) and saline group (10 ND fish, 8 HCD
fish, and 10 HFD fish). *p < 0.05 and **p < 0.01. Data shown as means ± SEM.
in obese Nile tilapia upon feeding on an HCD or HFD for
8 weeks.
DIO Nile Tilapia Selectively Retain Leptin
Action in Metabolic Regulation
To test whether leptin retains its actions in metabolic regulation
in DIO fish, NtrelepA injection was conducted in fish after
8 weeks of experimental feeding. The results showed that
NtrelepA treatment increased the plasma glucose level in ND-
and HFD-fed fish, but it remained unchanged in HCD-fed
fish, in either a GTT or a normal state (Figures 6A,B). In
contrast, NtrelepA treatment decreased plasma TG and increased
plasma NEFA in ND- and HCD-fed fish, but did not change
these parameters in HFD-fed fish (Figures 6C,D). The results
demonstrate that both HCD and HFD induced LR, but the
regulatory action of leptin was selectively retained in lipid
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FIGURE 6 | DIO Nile tilapia with LR presented selective regulation of leptin in lipid or glucose metabolism. (A) NtrelepA administration effects on glucose tolerance test
(n = 5). (B–D) NtrelepA administration effects on plasma glucose, TG and NEFA levels (n = 6). (E) ATGL and apoE mRNA in liver (n = 6). (F) Glut2 mRNA in liver
(n = 6). (G) FPKM of Glut2, ATGL, and apoE in liver. (H–K) Gene expression analysis 2 h after NtrelepA administration (n = 6). ATGL mRNA levels in liver (H). LPL and
CPT1a mRNA levels in liver (I,J). Glut2 mRNA levels in liver (K). *p < 0.05 and **p < 0.01. Data shown as means ± SEM.
metabolism in HCD-DIO fish and in glucose metabolism in
HFD-DIO fish.
Selectively-Retained Leptin Action Is
Beneficial for Surplus Calories Storage
To clarify the selective regulatory actions of leptin in metabolism
in DIO fish, we determined the mRNA expression of leptin-
regulated genes under hyperleptinemic states by qPCR.
Interestingly, HCD-fed fish exhibited increased ATGL and apoE
expression in liver, but had a decreased Glut2 expression in
the same tissue. In contrast, HFD-fed fish exhibited decreased
ATGL and apoE expression, but maintained the expression of
Glut2 in the liver (Figures 6E,F). These findings were confirmed
by transcriptomic analysis (Figure 6G). Next, we determined
the expression of these genes upon NtrelepA administration.
The mRNA levels of lipid metabolism-related genes, such
as ATGL, LPL, and CPT1a, were increased by NtrelepA in
ND- and HCD-fed fish, but remained unchanged in HFD-fed
fish (Figures 6H–J), suggesting LepA abated the ability to
regulate lipid metabolism. Fish fed with ND and those treated
with NtrelepA had an increased expression of Glut2 mRNA
in the liver, but no change was obtained in HCD-fed fish
(Figure 6K), suggesting that LepA weakened the regulation of
glucose metabolism in HCD-fed fish. These findings provide
biochemical and molecular evidences that HCD-DIO fish
retain the action of leptin in lipid metabolism, while HFD-DIO
fish retain its action in glucose metabolism. This selective LR
could be correlated with a previous theory that HFD-induced
obesity required the blockade of leptin action for surplus calorie
storage (25). Accordingly, we generated a diagram to reveal
the selective blockade of leptin action in metabolic regulation
when obesity was induced in fish by feeding on an HCD or HFD
(Figure 7).
Fasting for 1 Week Restores Leptin
Regulation in DIO Nile Tilapia
For animals in the wild, surplus calorie storage is essential to
deal with unpredictable starvation. To determine whether the lost
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FIGURE 7 | Diagram of selective metabolic regulation of leptin in DIO Nile tilapia induced by HCD or HFD feeding.
function of leptin in metabolic regulation could be recovered by
fasting, fish were deprived of their diet for 1 week after 8 weeks of
feeding, which were named as CD-F, HCD-F, and HFD-F groups.
The fish were then i.p. injected with NtrelepA (400 ng/g BW) or
saline to determine the action of leptin. Two hours after NtrelepA
injection, the plasma glucose level increased significantly and the
TG level decreased in all the three groups (Figures 8A,B). In
response to this, liver glycogen and TG decreased significantly
(Figures 8C,D). These results indicate that leptin could restore
mobilization of the two major stored energy components to
maintain normal physiological activities when the fish were
deprived of feed.
DISCUSSION
In the present study, we confirmed that liver and SCAT are the
two organs with higher expression of LepA in Nile tilapia. In
DIO Nile tilapia, hyperleptinemia occurred along with the loss of
the action of exogenous leptin to regulate food intake and body
weight, demonstrating the existence of LR in Nile tilapia. More
importantly, we found that HCD-DIO Nile tilapia retained the
action of leptin in regulating lipid metabolism, while presenting
LR in glucose metabolism regulation. Conversely, HFD-DIO
Nile tilapia retained the action of leptin in regulating glucose
metabolism while showed LR in lipid metabolism regulation.
This indicates for the first time the selective metabolic regulation
of leptin in DIO Nile tilapia with LR.
Leptin has been described as an adipostatic factor in mammals
given its secretion predominantly by adipose tissue and in
proportion to total adipose mass (21). However, the expression
of leptin is barely detected in adipose tissue of chicken and quails
(26). In addition, low level of leptin in liver and adipose tissue was
also reported in frogs (27). In teleosts, liver has been considered
to be the primary site for leptin synthesis, while there is almost
no leptin expression in VAT (28). Here, using IHC analysis with
a LepA-specific antibody, our data show that, besides liver, SCAT,
a commonly underappreciated tissue with higher lipid catabolic
activity than VAT (29) in Nile tilapia, also synthesized a high level
of LepA. Remarkably, SCATwas also reported to contributemore
leptin than visceral adipocytes in humans (30). In this regard, our
findings established a connection between mammals and teleosts
regarding the source of leptin.
In mammals, leptin regulates metabolic processes by reducing
TG content and increasing FA β-oxidation (31), while increasing
the incorporation of glucose into glycogen and reducing plasma
glucose (32). However, the existing data in teleosts suggested
that leptin stimulates glycogen depletion and elevates plasma
glucose, but there are conflicting data on its lipolytic actions
(10). Our data further confirmed that teleostean leptin induces
not only glycolytic action, but also lipolytic action in teleosts. As
endotherms, mammals have higher metabolic rates to maintain
body temperature and normal physiological activities (33), and
glucose is an efficient fuel for metabolism. Therefore, leptin in
mammals may promote gluconeogenesis, but not glycogenolysis,
which would allow glycogen stores to be conserved in the
event of a sudden high energy demand (10). On the contrary,
poikilotherms such as fish, cannot use glucose efficiently as
a fuel (34) compared with mammals, which may explain the
difference in the regulation of leptin in glycometabolism between
teleosts and mammals. However, these findings merit further
investigations to unveil the detailed mechanisms.
DIO, especially HFD-induced obesity with LR, has been
discussed extensively in mammals (3). In the present study, Nile
tilapia fed HCD or HFD for 8 weeks gained more body weight
and body fat than ND-fed fish. In mammals, lipid accumulation
can be promoted by periostin via inhibiting PPARα gene
transcription (35), while high level of RBP4 also promotes lipid
accumulation by inducing PPARγ gene transcription (36). In our
DIO Nile tilapia, HCD-fed fish had lower PPARα and higher
periostin expression, while HFD-fed fish had higher PPARγ and
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FIGURE 8 | Recovered actions of injected NtrelepA in metabolism regulation after 1 week fasting in DIO Nile tilapia. (A,B) Plasma glucose and TG levels (n = 6). (C,D)
Liver glycogen and TG content (n = 6). *p < 0.05 and **p < 0.01. Data shown as means ± SEM.
RBP4 expression. This shows that both HCD and HFD induced
obesity, but the mechanisms may be different between the two
models. Consistent with the findings in HFD-induced obese mice
(37), in both DIO fish models hyperleptinemia appeared and
exogenous leptin administration failed to regulate food intake
and body weight. This confirms the existence of LR in Nile tilapia.
Previous studies conducted on mammals defined LR as a loss of
the ability of leptin to regulate food intake (3). However, studies
also indicated that, in obesity with LR, leptin still retained actions
that resulted in the development of hypertension, which is known
as selective LR (38, 39). In addition, HFD fed mice reduced
leptin-induced p-STAT3 in the arcuate nucleus, while retaining
leptin sensitivity in other hypothalamic and extrahypothalamic
nuclei (24). Moreover, a recent study demonstrated that DIO
mice retained the ability of endogenous leptin to regulate food
intake and body weight (5). Therefore, leptin may retain more
of its activities in animals with LR than previously believed. It
should be noted that the resistance to the metabolic actions of
leptin has also been attributed to LR by default (39). Although
studies demonstrated that the stimulatory effect of leptin on
acetyl-CoA carboxylase activity or lipid oxidation was eliminated
inHFD-inducedDIOmice (40, 41), the action of leptin in glucose
metabolism was not investigated in previous studies.
A key finding of the present study is the selective retention
of the metabolic regulatory actions of leptin in two types of
DIO Nile tilapia with LR. In the wild, animals have surplus
calorie storage when food is abundant, which is critical to
prolonging survival during times of famine (42). In other words,
the rapid accumulation of body fat when food is abundant
is an adaptive strategy of animals to deal with sudden food
shortages. In C57BL/6J mice, HFD-induced obesity and LR are
fully reversible once food intake is resumed on a chow diet,
even with the same amount of calories intake as HFD group
(43). This suggests that it is macronutrient composition that
causes weight gain in DIO mice and not the total calories
consumed (43). More recently, Riddle and colleagues reported
that cavefish, Mexican tetra (Astyanax mexicanus) which carries
a mutation in the insulin receptor lead to insulin resistance,
and this phenotype is beneficial to weight gain for survival in
nutrient-limited environment (44). Moreover, the occurrence of
LR in zebrafish larvae promoted excessive caloric intake when
food resources were plentiful, suggesting LR could be an ancient
mechanism to promote somatic growth (45). In the present two
different DIO Nile tilapia models, carbohydrate represents the
main energy source in HCD while lipid is the main one in HFD.
From an adaptive evolutionary perspective, hyperleptinemia may
involve constant retention of the action to promote catabolism of
the minor energy source while maintaining resistance to trigger
catabolism of the primary energy source. This could provide a
major benefit by helping animals to store the primary nutrient-
containing energy and survive periods of food shortages. As an
additional evidence, the selective metabolic LR disappeared when
the HCD- or HFD-DIO Nile tilapia were fasted for 1 week,
indicating that this selective metabolic action of leptin occurs
when food is abundant. In mammals, the recovery of leptin
sensitivity was in parallel with the recovery of NPY/AgRP and
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POMC neurons’ response to leptin actions (43). In addition,
fasted mice with low cellular SOCS-3 levels enhanced greatly
leptin-induced p-STAT3 signals (46). Based on these findings,
1-week fasting might have improved the leptin-induced p-STAT3
signals and made the exogenous leptin recover its actions in
metabolic regulation.
Overall, we conclude that, in HCD- and HFD-DIO Nile
tilapia, hyperleptinemia and leptin resistance arise, but selective
leptin activity in energy expenditure is retained. From an
evolutionary and ecological perspectives, this finding of selective
blockade to the metabolic action of leptin may reveal an adaptive
strategy to store surplus calories efficiently.
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